The Board has remanded the case due to a need for additional medical opinions and development of records. The appellant contends that overmedication caused or contributed to her husband's death, but VA treatment records indicate appropriate care.
The deciding factor: The Court found insufficient evidence regarding whether overmedication or drug interactions from VA treatment caused or contributed to the Veteran's death.
- Claimed conditions
- atherosclerotic vascular disease
- How they argued it
- Not specified
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- October 29, 2009
- Citation
- 0941253
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Search VA.gov for the original decision (opens in a new tab) using citation 0941253.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Remanded (sent back)
The Board has decided to remand the case due to a duty-to-assist error, and will need to obtain a medical opinion regarding the etiology of the Veteran's cause of death.
- Whole decision: Granted
The Board has determined that the Veteran's disabilities caused by high cholesterol, including transient ischemic attack (TIA) and atherosclerotic vascular disease, are secondary to his service-connected chronic kidney disease with hypertension and diabetes mellitus. The claim is therefore granted.
- Whole decision: Remanded (sent back)
The Veteran's cause of death is remanded due to insufficient verification of herbicide exposure in Korea and CLCW exposure at Camp Lejeune. The AOJ must verify these exposures before service connection can be determined.
- Whole decision: Remanded (sent back)
The Board has remanded the claims for an effective date earlier than August 4, 2016, and a higher initial disability rating prior to April 13, 2021, for coronary artery disease due to further development being necessary.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.